STUDY OF ANTITUBERCULOSIS SIDE EFFECTS IN OUTPATIENTS IN ONE OF THE HOSPITALS AT GARUT
DOI:
https://doi.org/10.5614/api.v50i1.25067Keywords:
Adverse drug reaction, outpatient, tuberculosis, antituberculosisAbstract
Tuberculosis remains a global health problem with high incidence and mortality rates, 724,309 people infected with tuberculosis. One of the challenges in the treatment of tuberculosis is side effects of antituberculosis (OAT) which can lead to treatment discontinuation and drug resistance. This study aimed to identify the incidence of OAT side effects in outpatient tuberculosis patients at DOTS clinic in one of hospitals at Garut. This study used a descriptive survey design with a cross-sectional. Data were collected from 31 tuberculosis patients who met the inclusion criteria through interviews and medical records review during May-June 2024. Respondents used fixed dose combination (FDC) therapy (94% ) and single drug formulation(6%). OAT side effects are divided into mild and severe effects. The mild side effects most often experienced by respondents were redish urine (94%), flu-like symptoms (81%), and joint pain (77%). Meanwhile, the most common severe side effect experienced by respondents was visual (23%). Side effects are managed by administering symptomatic drugs such as antiemetics, analgesics, antipyretics, and vitamin B6. Intensive monitoring and appropriate management of side effects are essential to improve treatment adherence, prevent drug resistance, and reduce morbidity and mortality from tuberculosis.
References
Adriztina I, Adnan A, Haryuna SH, Siagian P, Sarumpaet S, 2014, Gangguan pendengaran dan keseimbangan pada penderita tuberkulosis yang mendapat pengobatan antituberkulosis kategori 1 dan 2, Jurnal Kesehatan Masyarakat Nasional 8 (8): 431 - 436, doi: 10.21109/kesmas.v8i8.416.
Ardiani T, Azmi RN, 2021, Identifikasi kejadian hepatotoksik pada pasien tuberkulosis dengan penggunaan obat anti tuberkulosis di Rumah Sakit Umum Daerah Abdul Wahab Sjahranie, Borneo Student Research 3(1): 978?985.
Bidarita W, Muhamad M, 2021, Analisis faktor umur, tingkat pendidikan, pekerjaan dan tuberkulosis paru di wilayah kerja Puskesmas Korleko, Kabupaten Lombok Timur, Jurnal Sanitasi dan Lingkungan 2(2): 173?184.
Budi, Iwan S, Yustini A, Indah PS, Dwi S, 2018, Analisis faktor risiko kejadian penyakit tuberkulosis bagi masyarakat daerah kumuh Kota Palembang, Jurnal Kesehatan Lingkungan Indonesia 17 (2): 87.
Dhhar G, McColl J, Kitai I, Levy DM, Verstegen RHJ, 2023, Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection, Can Med Assoc J 195(34): E1151?E1153. doi: 10.1503/cmaj.230317.
Farhanisa, Untari EK, Nansy E, 2018, Kejadian Efek Samping Obat Antituberkulosis (OAT) Kategori 1 pada Pasien Tuberkulosis Paru di Unit Pengobatan Penyakit Paru-Paru (UP4) Provinsi Kalimantan Barat, Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN 3(1): 1-12.
Nabilah EA, Triyani Y, Trusda SAD, 2022, Gambaran Usia dan Jenis Kelamin Pasien Tuberkulosis Rifampisin Sensitif Berdasar atas Tes Cepat Molekuler di RS-Al Islam Kota Bandung Tahun 2018-2019, Bandung Conference Series: Medical Science Volume 2, Bandung
Fatmawati U, Kusmiati T, 2017, Characteristics and the Side Effects of New MDR-TUBERKULOSIS Treatment in the Dr. Soetomo Hospital during 2016, Jurnal Respirasi 3(3): 67-73, doi: 10.20473/jr.v3-i.3.2017.67-73.
Fortuna TA, Rachmawati H, Hasmono D, Karuniawati H, 2022, Studi Penggunaan Obat Anti Tuberkulosis (OAT) Tahap Lanjutan pada Pasien Baru BTA Positif The Study of Continuation Phase Anti Tuberculosis Drugs (OAT) in New Patient with Smear-Positive, Pharmacon: Jurnal Farmasi Indonesia 19(1): 62?71, doi: 10.23917/pharmacon.v19i1.17907.
Fraga ADSS, Oktavia N, Mulia RA, 2021, Evaluasi Penggunaan Obat Anti Tuberkulosis Pasien Baru Tuberkulosis Paru di Puskesmas Oebobo Kupang, Jurnal Farmagazine 8(1): 17-24, doi: 10.47653/farm.v8i1.530.
Halim M, Sabrina A, Aris M, 2023, Kepatuhan pasien rawat jalan poli paru dalam penggunaan obat anti tuberkulosis (OAT) di Rumah Sakit Kartika Husada Jatiasih Bekasi, Jurnal Farmasi IKIFA 2(1): 30 - 37.
Kemenkes RI, 2023, Profil Kesehatan Indonesia. Kementerian Kesehatan Republik Indonesia, Jakarta.
Kementerian Kesehatan Republik Indonesia, 2020, Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulsosis. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis, Jakarta.
Kementerian Kesehatan Republik Indonesia, 2023, Laporan Program Penanggulangan Tuberkulosis Tahun 2022, Kemenkes RI, 1?156. https://tuberkulosisindonesia.or.id/pustaka_tuberkulosisc/laporan-tahunan-program-tuberkulosisc-2021/
Lazulfa RWA, Wirjatmadi B, Adriani M, 2016, Tingkat Kecukupan Zat Gizi Makro dan Status Gizi Pasien Tuberkulosis dengan Sputum BTA (+) dan Sputum BTA (?), Media Gizi Indonesia 11(2): 144?152, doi: 10.20473/mgi.v11i2.144-152.
Musdalipah M, Nurhikma E, Karmilah K Fakhrurazi, 2018, Efek Samping Obat Anti Tuberkulosis ( OAT ) dan Penanganannya pada Pasien Tuberkulosis ( Tuberkulosis ) Di Puskesmas Perumnas Kota Kendari. Jurnal Imiah Manuntung 4(1): 67?73.
Rosamarlina R, Lisdawati V, Banggai CE, Darayani, Pakki TR, Rogayah R, Murtiani F, 2019, Monitoring Efek Samping Obat Anti Tuberkulosis di Poli Tuberkulosis DOTS RSPI Prof. Dr. Sulianti Saroso, The Indonesian Journal of Infectious Disease 5(2): 10?20, doi: 10.32667/ijid.v5i2.81.
Sari ID, Yuniar Y, Syaripuddin M, 2014, Studi Monitoring Efek Samping Obat Antituberkulosis Fdc Kategori 1 Di Provinsi Banten Dan Provinsi Jawa Barat, Media Litbangkes 24(1): 28?35.
Sumual LR, Wahongan JPG, Tuda JSB, 2017, Deteksi Mycobacterium tuberculosis pada Sampel Sputum menggunakan Teknik Loop-Mediated Isothermal Amplification (LAMP-TUBERKULOSIS), Jurnal e-Biomedik, 5(2), doi: 10.35790/ebm.5.2.2017.18603.
Sunarmi S, Kurniawaty K, 2022, Hubungan Karakteristik Pasien Tuberkulosis Paru Dengan Kejadian Tuberkulosis, Jurnal ?Aisyiyah Medika, 7(2): 182?187, doi: 10.36729/jam.v7i2.865.
